Capstone Investment Advisors’s Protalix BioTherapeutics PLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-15,336	Closed	-$39.3K	–	998
2025 Q1	$39.3K	Buy	+15,336	New	+$39.3K	﹤0.01%	519
2021 Q2	–	Sell	-21,058	Closed	-$94K	–	939
2021 Q1	$94K	Sell	21,058 -1,094	-5%	-$4.88K	﹤0.01%	483
2020 Q4	$80K	Buy	+22,152	New	+$80K	﹤0.01%	494